Dr. Schreck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
201 North Broadway Street
Viragh BLDG 5th FL
Baltimore, MD 21287Phone+1 410-955-8964Fax+1 410-367-2194
Summary
- Dr. Karisa Schreck is a neurologist in Baltimore, MD and is affiliated with Johns Hopkins Hospital. She received her medical degree from Johns Hopkins University School of Medicine and has been in practice 5 years. She specializes in neurooncology and is experienced in oligodendroglioma, ependymoma, glioblastoma multiforme, and mixed glioma.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
- Johns Hopkins UniversityResidency, Neurology, 2013 - 2016
- Johns Hopkins UniversityInternship, Internal Medicine, 2012 - 2013
- Johns Hopkins University School of MedicineClass of 2012
Certifications & Licensure
- FL State Medical License 2021 - Present
- VA State Medical License 2023 - 2026
- MD State Medical License 2016 - 2025
- PA State Medical License 2024 - 2024
- NC State Medical License 2021 - 2022
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Glioma Modified Atkins-based Diet in Patients With Glioblastoma Start of enrollment: 2014 Nov 01
- A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas Start of enrollment: 2018 May 19
Roles: Contact, Principal Investigator
- Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG Start of enrollment: 2019 Jul 29
Publications & Presentations
PubMed
- Molecular characterization of gliosarcoma reveals prognostic biomarkers and clinical parallels with glioblastoma.Lucy Chen, Emanuelle Rizk, Mohamed Sherief, Michael Chang, Calixto-Hope Lucas
Journal of Neuro-Oncology. 2024-10-30 - NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.Michael Chang, Mohamed Sherief, Maria Ioannou, Viveka Chinnasamy, Lucy Chen
Acta Neuropathologica Communications. 2024-10-29 - Impact of upfront adjuvant chemoradiation on survival in patients with molecularly defined oligodendroglioma: the benefits of PCV over TMZ.Jordina Rincon-Torroella, Maureen Rakovec, Anita L Kalluri, Kelly Jiang, Carly Weber-Levine
Journal of Neuro-Oncology. 2024-10-09
Press Mentions
- New Mutations Enable Gliomas to Resist Proven Treatment, Study ShowsSeptember 24th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: